Elizaveta Mukhaleva

Elizaveta Mukhaleva

Auto-generated profile, based on publicly available information

Elizaveta Mukhaleva

Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, California, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
EMElizaveta Mukhaleva
Elizaveta Mukhaleva
NMNing Ma
Ning Ma
WVWijnand J.C. van der Velden
Wijnand J.C. van der Velden
GGGrigoriy Gogoshin
Grigoriy Gogoshin
SBSergio Branciamore
Sergio Branciamore
NVNagarajan Vaidehi
Nagarajan Vaidehi
Cooperative interactions in protein-protein interfaces demonstrate the interdependency or the linked network-like behavior and their effect on the coupling of proteins. Cooperative interactions also could cause ripple or allosteric effects at a distance in protein-protein interfaces. Although they are critically important in protein-protein interfaces, it is challenging to determine which amino acid pair interactions are cooperative. In this work, we have used Bayesian network modeling, an interpretable machine learning method, combined with molecular dynamics trajectories to identify the residue pairs that show high cooperativity and their allosteric effect in the interface of G protein-coupled receptor (GPCR) complexes with Gα subunits. Our results reveal six GPCR:Gα contacts that are common to the different Gα subtypes and show strong cooperativity in the formation of interface. Both the C terminus helix5 and the core of the G protein are codependent entities and play an important role in GPCR coupling. We show that a promiscuous GPCR coupling to different Gα subtypes, makes all the GPCR:Gα contacts that are specific to each Gα subtype (Gαs, Gαi, and Gαq). This work underscores the potential of data-driven Bayesian network modeling in elucidating the intricate dependencies and selectivity determinants in GPCR:G protein complexes, offering valuable insights into the dynamic nature of these essential cellular signaling components.

1 August 2019 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
ESE. V. Stelmashook
E. V. Stelmashook
EGE. E. Genrikhs
E. E. Genrikhs
EME. V. Mukhaleva
E. V. Mukhaleva
MKM. R. Kapkaeva
M. R. Kapkaeva
RKR. V. Kondratenko
R. V. Kondratenko
NIN K Isaev
N K Isaev

1 December 2017 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
TVTatiana V. Vygodina
Tatiana V. Vygodina
EMElizaveta Mukhaleva
Elizaveta Mukhaleva
NANatalia Azarkina
Natalia Azarkina
AKAlexander A. Konstantinov
Alexander A. Konstantinov

23 February 2024 in Science Advances
Verified
Journal Article
Open access
ACAnthony K.N. Chan
Anthony K.N. Chan
LHLi Han
Li Han
CDChristopher D. Delaney
Christopher D. Delaney
XWXueer Wang
Xueer Wang
EMElizaveta Mukhaleva
Elizaveta Mukhaleva
CCChun-Wei Chen
Chun-Wei Chen
Epigenetic dysregulation has been reported in multiple cancers including leukemias. Nonetheless, the roles of the epigenetic reader Tudor domains in leukemia progression and therapy remain unexplored. Here, we conducted a Tudor domain–focused CRISPR screen and identified SGF29, a component of SAGA/ATAC acetyltransferase complexes, as a crucial factor for H3K9 acetylation, ribosomal gene expression, and leukemogenesis. To facilitate drug development, we integrated the CRISPR tiling scan with compound docking and molecular dynamics simulation, presenting a generally applicable strategy called CRISPR-Scan Assisted Drug Discovery (CRISPR-SADD). Using this approach, we identified a lead inhibitor that selectively targets SGF29’s Tudor domain and demonstrates efficacy against leukemia. Furthermore, we propose that the structural genetics approach used in our study can be widely applied to diverse fields for de novo drug discovery.

23 January 2025 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
EMElizaveta Mukhaleva
Elizaveta Mukhaleva
BMBabgen Manookian
Babgen Manookian
HCHanyu Chen
Hanyu Chen
ISIndira R. Sivaraj
Indira R. Sivaraj
NMNing Ma
Ning Ma
SBSergio Branciamore
Sergio Branciamore

23 March 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TLTyler J. Lefevre
Tyler J. Lefevre
WWWenyuan Wei
Wenyuan Wei
EMElizaveta Mukhaleva
Elizaveta Mukhaleva
SVSai Pranathi Meda Venkata
Sai Pranathi Meda Venkata
NCNaincy R. Chandan
Naincy R. Chandan
ASAlan V. Smrcka
Alan V. Smrcka
Highly homologous members of the Gαi family, Gαi1-3, have distinct tissue distributions and physiological functions, yet their biochemical and functional properties are very similar. We recently identified PDZ-RhoGEF (PRG) as a novel Gαi1 effector that is poorly activated by Gαi2. In a proteomic proximity labeling screen we observed a strong preference for Gαi1 relative to Gαi2 with respect to engagement of a broad range of potential targets. We investigated the mechanistic basis for this selectivity using PRG as a representative target. Substitution of either the helical domain (HD) from Gαi1 into Gαi2 or substitution of a single amino acid, A230 in Gαi2 with the corresponding D in Gαi1, largely rescues PRG activation and interactions with other potential Gαi targets. Molecular dynamics simulations combined with Bayesian network models revealed that in the GTP bound state, separation at the HD-Ras-like domain (RLD) interface is more pronounced in Gαi2 than Gαi1. Mutation of A230 to D in Gαi2 stabilizes HD-RLD interactions via ionic interactions with R145 in the HD which in turn modify the conformation of Switch III. These data support a model where D229 in Gαi1 interacts with R144 and stabilizes a network of interactions between HD and RLD to promote protein target recognition. The corresponding A230 in Gαi2 is unable to stabilize this network leading to an overall lower efficacy with respect to target interactions. This study reveals distinct mechanistic properties that could underly differential biological and physiological consequences of activation of Gαi1 or Gαi2 by G protein-coupled receptors.